
<div id="jpedal" style="overflow: hidden; position: relative; width: 909px; height: 1212px;">
<style type="text/css" >
.t {
	-webkit-transform-origin: top left;
	-moz-transform-origin: top left;
	-o-transform-origin: top left;
	-ms-transform-origin: top left;
	-webkit-transform: scale(0.25);
	-moz-transform: scale(0.25);
	-o-transform: scale(0.25);
	-ms-transform: scale(0.25);
	z-index: 2;
	position:absolute;
	white-space:nowrap;
	overflow:visible;
}
</style>
<style type="text/css" >

#t1_4{left:100px;top:122px;letter-spacing:-0.1px;word-spacing:2.9px;}
#t2_4{left:100px;top:139px;word-spacing:8.9px;}
#t3_4{left:251px;top:139px;letter-spacing:0.2px;word-spacing:8.3px;}
#t4_4{left:288px;top:137px;}
#t5_4{left:306px;top:139px;word-spacing:9px;}
#t6_4{left:100px;top:155px;word-spacing:9.8px;}
#t7_4{left:100px;top:172px;word-spacing:7px;}
#t8_4{left:100px;top:189px;word-spacing:18.9px;}
#t9_4{left:100px;top:205px;letter-spacing:-0.2px;word-spacing:1.2px;}
#ta_4{left:100px;top:222px;word-spacing:20.6px;}
#tb_4{left:100px;top:239px;word-spacing:22.3px;}
#tc_4{left:100px;top:256px;letter-spacing:-0.1px;word-spacing:14.1px;}
#td_4{left:100px;top:272px;word-spacing:20.2px;}
#te_4{left:100px;top:289px;letter-spacing:0.1px;word-spacing:27.6px;}
#tf_4{left:100px;top:306px;word-spacing:36.7px;}
#tg_4{left:100px;top:323px;word-spacing:27.5px;}
#th_4{left:100px;top:339px;word-spacing:5.8px;}
#ti_4{left:100px;top:356px;word-spacing:20.3px;}
#tj_4{left:100px;top:373px;word-spacing:5.2px;}
#tk_4{left:116px;top:390px;}
#tl_4{left:157px;top:390px;}
#tm_4{left:292px;top:390px;letter-spacing:0.1px;}
#tn_4{left:395px;top:390px;}
#to_4{left:423px;top:390px;letter-spacing:0.1px;}
#tp_4{left:100px;top:406px;word-spacing:38.8px;}
#tq_4{left:100px;top:423px;letter-spacing:0.1px;}
#tr_4{left:164px;top:423px;word-spacing:15.1px;}
#ts_4{left:198px;top:423px;}
#tt_4{left:202px;top:421px;}
#tu_4{left:222px;top:423px;word-spacing:15.3px;}
#tv_4{left:100px;top:440px;letter-spacing:0.1px;word-spacing:25.6px;}
#tw_4{left:100px;top:457px;letter-spacing:-0.1px;word-spacing:16.8px;}
#tx_4{left:100px;top:473px;letter-spacing:-0.1px;word-spacing:1.6px;}
#ty_4{left:100px;top:490px;letter-spacing:0.1px;word-spacing:3.1px;}
#tz_4{left:100px;top:507px;word-spacing:29.6px;}
#t10_4{left:100px;top:524px;letter-spacing:0.1px;word-spacing:16.6px;}
#t11_4{left:100px;top:540px;}
#t12_4{left:100px;top:557px;letter-spacing:0.1px;word-spacing:16.6px;}
#t13_4{left:100px;top:574px;word-spacing:33.6px;}
#t14_4{left:411px;top:574px;word-spacing:33.5px;}
#t15_4{left:453px;top:572px;}
#t16_4{left:100px;top:591px;letter-spacing:0.1px;word-spacing:12.4px;}
#t17_4{left:100px;top:607px;letter-spacing:-0.1px;word-spacing:15.5px;}
#t18_4{left:100px;top:624px;letter-spacing:-0.1px;word-spacing:1.7px;}
#t19_4{left:100px;top:641px;word-spacing:8.8px;}
#t1a_4{left:100px;top:658px;letter-spacing:-0.1px;word-spacing:19.9px;}
#t1b_4{left:100px;top:674px;}
#t1c_4{left:106px;top:674px;}
#t1d_4{left:120px;top:674px;}
#t1e_4{left:134px;top:674px;word-spacing:0.9px;}
#t1f_4{left:100px;top:691px;word-spacing:23.4px;}
#t1g_4{left:100px;top:708px;letter-spacing:-0.1px;word-spacing:18.1px;}
#t1h_4{left:100px;top:725px;word-spacing:15.1px;}
#t1i_4{left:100px;top:741px;word-spacing:8.2px;}
#t1j_4{left:100px;top:758px;word-spacing:33.4px;}
#t1k_4{left:100px;top:775px;word-spacing:-0.3px;}
#t1l_4{left:100px;top:792px;word-spacing:14.5px;}
#t1m_4{left:100px;top:808px;word-spacing:19.7px;}
#t1n_4{left:100px;top:825px;word-spacing:4.4px;}
#t1o_4{left:296px;top:825px;}
#t1p_4{left:311px;top:825px;word-spacing:4.5px;}
#t1q_4{left:100px;top:842px;word-spacing:2.2px;}
#t1r_4{left:100px;top:858px;word-spacing:-0.3px;}
#t1s_4{left:100px;top:875px;word-spacing:30.6px;}
#t1t_4{left:100px;top:892px;word-spacing:21.1px;}
#t1u_4{left:100px;top:909px;letter-spacing:0.1px;word-spacing:9.7px;}
#t1v_4{left:280px;top:907px;}
#t1w_4{left:314px;top:909px;word-spacing:9.8px;}
#t1x_4{left:100px;top:925px;word-spacing:19.4px;}
#t1y_4{left:191px;top:925px;word-spacing:19.3px;}
#t1z_4{left:229px;top:924px;}
#t20_4{left:251px;top:925px;word-spacing:19.4px;}
#t21_4{left:100px;top:942px;word-spacing:30.3px;}
#t22_4{left:100px;top:959px;letter-spacing:-0.3px;word-spacing:13.9px;}
#t23_4{left:100px;top:976px;letter-spacing:0.1px;word-spacing:11px;}
#t24_4{left:100px;top:992px;word-spacing:9.2px;}
#t25_4{left:100px;top:1009px;word-spacing:3.7px;}
#t26_4{left:100px;top:1026px;word-spacing:3.5px;}
#t27_4{left:100px;top:1043px;letter-spacing:0.1px;word-spacing:24.8px;}
#t28_4{left:100px;top:1059px;letter-spacing:-0.1px;word-spacing:5.5px;}
#t29_4{left:100px;top:1076px;word-spacing:3.8px;}
#t2a_4{left:100px;top:1093px;word-spacing:2.8px;}
#t2b_4{left:100px;top:1110px;word-spacing:5.1px;}
#t2c_4{left:508px;top:122px;word-spacing:17.8px;}
#t2d_4{left:493px;top:139px;word-spacing:10.4px;}
#t2e_4{left:493px;top:155px;letter-spacing:0.1px;word-spacing:3.3px;}
#t2f_4{left:493px;top:172px;letter-spacing:0.1px;word-spacing:6px;}
#t2g_4{left:493px;top:189px;word-spacing:15.4px;}
#t2h_4{left:493px;top:205px;word-spacing:10.2px;}
#t2i_4{left:493px;top:222px;letter-spacing:-0.1px;word-spacing:29.5px;}
#t2j_4{left:493px;top:239px;word-spacing:29.2px;}
#t2k_4{left:493px;top:256px;letter-spacing:-0.1px;word-spacing:5.5px;}
#t2l_4{left:493px;top:306px;word-spacing:5.4px;}
#t2m_4{left:493px;top:323px;word-spacing:30px;}
#t2n_4{left:493px;top:339px;word-spacing:17.4px;}
#t2o_4{left:493px;top:356px;letter-spacing:-0.1px;word-spacing:24.3px;}
#t2p_4{left:493px;top:373px;letter-spacing:0.1px;word-spacing:32.7px;}
#t2q_4{left:493px;top:390px;word-spacing:11.7px;}
#t2r_4{left:493px;top:407px;letter-spacing:0.1px;word-spacing:10.6px;}
#t2s_4{left:759px;top:405px;}
#t2t_4{left:771px;top:407px;letter-spacing:-0.3px;word-spacing:10.9px;}
#t2u_4{left:493px;top:423px;letter-spacing:-0.2px;word-spacing:21.8px;}
#t2v_4{left:779px;top:423px;word-spacing:21.4px;}
#t2w_4{left:818px;top:422px;}
#t2x_4{left:840px;top:423px;}
#t2y_4{left:493px;top:440px;word-spacing:11.7px;}
#t2z_4{left:493px;top:457px;word-spacing:4.2px;}
#t30_4{left:493px;top:473px;word-spacing:9.4px;}
#t31_4{left:493px;top:490px;word-spacing:25.9px;}
#t32_4{left:493px;top:507px;}
#t33_4{left:493px;top:524px;word-spacing:11.8px;}
#t34_4{left:493px;top:540px;letter-spacing:0.1px;}
#t35_4{left:508px;top:557px;word-spacing:9.3px;}
#t36_4{left:493px;top:574px;word-spacing:17.3px;}
#t37_4{left:493px;top:591px;word-spacing:6.9px;}
#t38_4{left:830px;top:589px;}
#t39_4{left:493px;top:607px;}
#t3a_4{left:538px;top:607px;letter-spacing:0.1px;word-spacing:3px;}
#t3b_4{left:572px;top:606px;}
#t3c_4{left:590px;top:607px;word-spacing:3.3px;}
#t3d_4{left:493px;top:624px;word-spacing:3.7px;}
#t3e_4{left:493px;top:641px;letter-spacing:0.1px;word-spacing:6.1px;}
#t3f_4{left:493px;top:658px;letter-spacing:0.1px;word-spacing:13.5px;}
#t3g_4{left:493px;top:674px;letter-spacing:0.1px;word-spacing:35.6px;}
#t3h_4{left:493px;top:691px;word-spacing:18.9px;}
#t3i_4{left:493px;top:708px;word-spacing:3px;}
#t3j_4{left:798px;top:708px;}
#t3k_4{left:806px;top:708px;word-spacing:2.8px;}
#t3l_4{left:493px;top:725px;word-spacing:7.5px;}
#t3m_4{left:493px;top:741px;word-spacing:25px;}
#t3n_4{left:493px;top:758px;word-spacing:24.5px;}
#t3o_4{left:493px;top:775px;letter-spacing:-0.1px;word-spacing:1.3px;}
#t3p_4{left:493px;top:792px;word-spacing:22.2px;}
#t3q_4{left:493px;top:808px;word-spacing:5.3px;}
#t3r_4{left:508px;top:825px;letter-spacing:0.1px;}
#t3s_4{left:607px;top:825px;letter-spacing:0.1px;word-spacing:34.2px;}
#t3t_4{left:650px;top:823px;}
#t3u_4{left:675px;top:825px;word-spacing:34.4px;}
#t3v_4{left:493px;top:842px;word-spacing:15.1px;}
#t3w_4{left:493px;top:859px;word-spacing:35.2px;}
#t3x_4{left:493px;top:875px;word-spacing:6.7px;}
#t3y_4{left:493px;top:892px;letter-spacing:0.1px;word-spacing:3.6px;}
#t3z_4{left:493px;top:909px;}
#t40_4{left:526px;top:909px;}
#t41_4{left:534px;top:909px;word-spacing:15.2px;}
#t42_4{left:657px;top:909px;}
#t43_4{left:665px;top:909px;word-spacing:15px;}
#t44_4{left:493px;top:925px;word-spacing:1px;}
#t45_4{left:493px;top:942px;letter-spacing:-0.1px;word-spacing:2.9px;}
#t46_4{left:493px;top:959px;word-spacing:12.9px;}
#t47_4{left:493px;top:976px;word-spacing:38.8px;}
#t48_4{left:639px;top:976px;word-spacing:39.2px;}
#t49_4{left:755px;top:976px;word-spacing:39.3px;}
#t4a_4{left:493px;top:992px;word-spacing:23.5px;}
#t4b_4{left:493px;top:1009px;word-spacing:17.4px;}
#t4c_4{left:493px;top:1026px;}
#t4d_4{left:587px;top:1026px;}
#t4e_4{left:629px;top:1026px;}
#t4f_4{left:720px;top:1026px;}
#t4g_4{left:767px;top:1026px;letter-spacing:0.1px;}
#t4h_4{left:845px;top:1026px;}
#t4i_4{left:493px;top:1043px;word-spacing:38px;}
#t4j_4{left:493px;top:1059px;word-spacing:13.6px;}
#t4k_4{left:493px;top:1076px;word-spacing:10.4px;}
#t4l_4{left:493px;top:1093px;word-spacing:9.7px;}
#t4m_4{left:493px;top:1110px;word-spacing:0.8px;}
#t4n_4{left:176px;top:79px;word-spacing:4.2px;}
#t4o_4{left:391px;top:92px;word-spacing:4.2px;}
#t4p_4{left:447px;top:92px;word-spacing:4px;}
#t4q_4{left:55px;top:114px;}
#t4r_4{left:55px;top:1143px;word-spacing:4.6px;}

.s4_4{
	FONT-SIZE: 60.9px;
	FONT-FAMILY: CAAOGJ-AdvP4C4E744;
	color: rgb(0,0,0);
}

.s6_4{
	FONT-SIZE: 40.6px;
	FONT-FAMILY: CAAPBI-AdvEls-ent34;
	color: rgb(0,0,0);
}

.s8_4{
	FONT-SIZE: 48.7px;
	FONT-FAMILY: CAANIJ-AdvNewsGothicB4;
	color: rgb(0,0,0);
}

.s5_4{
	FONT-SIZE: 60.9px;
	FONT-FAMILY: CAAPAI-AdvEls-ent44;
	color: rgb(0,0,0);
}

.s9_4{
	FONT-SIZE: 48.7px;
	FONT-FAMILY: CAANIK-AdvNewsGothicR4;
	color: rgb(0,0,0);
}

.s10_4{
	FONT-SIZE: 48.7px;
	FONT-FAMILY: CAAOEI-AdvNewsGothicI4;
	color: rgb(0,0,0);
}

.s11_4{
	FONT-SIZE: 51.8px;
	FONT-FAMILY: CAAOEJ-AdvUN-Bold4;
	color: rgb(0,0,0);
}

.s7_4{
	FONT-SIZE: 60.9px;
	FONT-FAMILY: CAANLL-AdvPi14;
	color: rgb(0,0,0);
}

.s3_4{
	FONT-SIZE: 40.6px;
	FONT-FAMILY: CAAMPK-AdvMelior-R4;
	color: rgb(0,0,0);
}

.s1_4{
	FONT-SIZE: 60.9px;
	FONT-FAMILY: CAAMPK-AdvMelior-R4;
	color: rgb(0,0,0);
}

.s2_4{
	FONT-SIZE: 60.9px;
	FONT-FAMILY: CAAMPL-AdvMelior-I4;
	color: rgb(0,0,0);
}

.v3_4{
	-webkit-transform: scale(0.149, 0.25);
	-ms-transform: scale(0.149, 0.25);
	-moz-transform: scale(0.149, 0.25);
	-o-transform: scale(0.149, 0.25);
}

.v1_4{
	-webkit-transform: scale(0.281, 0.25);
	-ms-transform: scale(0.281, 0.25);
	-moz-transform: scale(0.281, 0.25);
	-o-transform: scale(0.281, 0.25);
}

.v2_4{
	-webkit-transform: scale(0.199, 0.25);
	-ms-transform: scale(0.199, 0.25);
	-moz-transform: scale(0.199, 0.25);
	-o-transform: scale(0.199, 0.25);
}

#form4_1{	border-style:none;	z-index:2;	position: absolute;	left:287px;	top:135px;	width:14px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_2{	border-style:none;	z-index:2;	position: absolute;	left:649px;	top:821px;	width:14px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_3{	border-style:none;	z-index:2;	position: absolute;	left:202px;	top:419px;	width:14px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_4{	border-style:none;	z-index:2;	position: absolute;	left:229px;	top:921px;	width:14px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_5{	border-style:none;	z-index:2;	position: absolute;	left:818px;	top:419px;	width:14px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_6{	border-style:none;	z-index:2;	position: absolute;	left:452px;	top:569px;	width:14px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_7{	border-style:none;	z-index:2;	position: absolute;	left:572px;	top:602px;	width:14px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_8{	border-style:none;	z-index:2;	position: absolute;	left:830px;	top:585px;	width:29px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_9{	border-style:none;	z-index:2;	position: absolute;	left:280px;	top:905px;	width:29px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}

</style>
<style id="fonts4" type="text/css" >

@font-face {
	font-family: CAAPAI-AdvEls-ent44;
	src: url("4/fonts/CAAPAI-AdvEls-ent4.woff") format("woff");
}

@font-face {
	font-family: CAAOGJ-AdvP4C4E744;
	src: url("4/fonts/CAAOGJ-AdvP4C4E74.woff") format("woff");
}

@font-face {
	font-family: CAAOEJ-AdvUN-Bold4;
	src: url("4/fonts/CAAOEJ-AdvUN-Bold.woff") format("woff");
}

@font-face {
	font-family: CAAPBI-AdvEls-ent34;
	src: url("4/fonts/CAAPBI-AdvEls-ent3.woff") format("woff");
}

@font-face {
	font-family: CAAMPL-AdvMelior-I4;
	src: url("4/fonts/CAAMPL-AdvMelior-I.woff") format("woff");
}

@font-face {
	font-family: CAANLL-AdvPi14;
	src: url("4/fonts/CAANLL-AdvPi1.woff") format("woff");
}

@font-face {
	font-family: CAAOEI-AdvNewsGothicI4;
	src: url("4/fonts/CAAOEI-AdvNewsGothicI.woff") format("woff");
}

@font-face {
	font-family: CAANIK-AdvNewsGothicR4;
	src: url("4/fonts/CAANIK-AdvNewsGothicR.woff") format("woff");
}

@font-face {
	font-family: CAANIJ-AdvNewsGothicB4;
	src: url("4/fonts/CAANIJ-AdvNewsGothicB.woff") format("woff");
}

@font-face {
	font-family: CAAMPK-AdvMelior-R4;
	src: url("4/fonts/CAAMPK-AdvMelior-R.woff") format("woff");
}

</style>
<div id="t1_4" class="t s1_4">(for example nightly, four time per week and so on),</div>
<div id="t2_4" class="t s1_4">a study by Montorsi</div>
<div id="t3_4" class="t s2_4">et al.</div>
<div id="t4_4" class="t v1_4 s3_4">23</div>
<div id="t5_4" class="t s1_4">was unable to demon-</div>
<div id="t6_4" class="t s1_4">strate a difference in functional outcomes between</div>
<div id="t7_4" class="t s1_4">patients on demand-dose PDE-5 inhibitors versus a</div>
<div id="t8_4" class="t s1_4">formal EP program schedule in a three-arm con-</div>
<div id="t9_4" class="t s1_4">trolled study. However, this study neither assessed a</div>
<div id="ta_4" class="t s1_4">comprehensive EP program nor did it document</div>
<div id="tb_4" class="t s1_4">compliance with regular PDE-5 inhibitor dosing.</div>
<div id="tc_4" class="t s1_4">Additionally, it was composed of numerous treat-</div>
<div id="td_4" class="t s1_4">ment sites and did not control for surgeon skill</div>
<div id="te_4" class="t s1_4">in preserving the cavernosal nerves. Thus, this</div>
<div id="tf_4" class="t s1_4">outcome cannot be extrapolated to all formal</div>
<div id="tg_4" class="t s1_4">EP regimens. Despite the statistical equivalence</div>
<div id="th_4" class="t s1_4">between these two groups, each showed a dramatic</div>
<div id="ti_4" class="t s1_4">improvement in erectile function compared with</div>
<div id="tj_4" class="t s1_4">the control group.</div>
<div id="tk_4" class="t s1_4">The</div>
<div id="tl_4" class="t s1_4">pathophysiologic</div>
<div id="tm_4" class="t s1_4">modification</div>
<div id="tn_4" class="t s1_4">of</div>
<div id="to_4" class="t s1_4">PDE-5</div>
<div id="tp_4" class="t s1_4">inhibitors can also be observed histologically.</div>
<div id="tq_4" class="t s1_4">Mulhall</div>
<div id="tr_4" class="t s2_4">et al</div>
<div id="ts_4" class="t s1_4">.</div>
<div id="tt_4" class="t v1_4 s3_4">24</div>
<div id="tu_4" class="t s1_4">observed the role of sildenafil in</div>
<div id="tv_4" class="t s1_4">preservation of erectile function after cavernous</div>
<div id="tw_4" class="t s1_4">nerve crush injury. In a rat model for cavernosal</div>
<div id="tx_4" class="t s1_4">nerve injury, the authors demonstrated maintenance</div>
<div id="ty_4" class="t s1_4">of cavernosal smooth muscle integrity and observed</div>
<div id="tz_4" class="t s1_4">a trend in favor of improved erectile function</div>
<div id="t10_4" class="t s1_4">outcomes. The authors attribute this to improved</div>
<div id="t11_4" class="t s1_4">penile hemodynamics immediately after injury, thus</div>
<div id="t12_4" class="t s1_4">preventing smooth muscle apoptosis with perma-</div>
<div id="t13_4" class="t s1_4">nent damage to the tissues. Schwartz</div>
<div id="t14_4" class="t s2_4">et al.</div>
<div id="t15_4" class="t v1_4 s3_4">14</div>
<div id="t16_4" class="t s1_4">demonstrated the dose-dependant impact of silde-</div>
<div id="t17_4" class="t s1_4">nafil on corporal smooth muscle after RP. In this</div>
<div id="t18_4" class="t s1_4">study, two groups (50 and 100 mg of sildenafil every</div>
<div id="t19_4" class="t s1_4">other night) were biopsied at the time of RP and 6</div>
<div id="t1a_4" class="t s1_4">months post-operatively. While their small study</div>
<div id="t1b_4" class="t s1_4">(</div>
<div id="t1c_4" class="t s2_4">N</div>
<div id="t1d_4" class="t s4_4">¼</div>
<div id="t1e_4" class="t s1_4">21) lacks a control group because of concern for</div>
<div id="t1f_4" class="t s1_4">the psychological trauma associated with the 6-</div>
<div id="t1g_4" class="t s1_4">month post-RP biopsy, the patients in the 50-mg</div>
<div id="t1h_4" class="t s1_4">group maintained pre-RP corporal smooth muscle</div>
<div id="t1i_4" class="t s1_4">levels, whereas the patients in the 100-mg actually</div>
<div id="t1j_4" class="t s1_4">had a significant increase in post-RP corporal</div>
<div id="t1k_4" class="t s1_4">smooth muscle (as a percent of the histologic section</div>
<div id="t1l_4" class="t s1_4">assessed by a computer-based analysis tool). At 6</div>
<div id="t1m_4" class="t s1_4">months, the overall prevalence of veno-occlusive</div>
<div id="t1n_4" class="t s1_4">disease in both groups was</div>
<div id="t1o_4" class="t s5_4">o</div>
<div id="t1p_4" class="t s1_4">5% (one patient). The</div>
<div id="t1q_4" class="t s1_4">authors comment on other reports of the chronology</div>
<div id="t1r_4" class="t s1_4">of post-RP veno-occlusive disease where evidence of</div>
<div id="t1s_4" class="t s1_4">disease is present in at least 50% of post-RP</div>
<div id="t1t_4" class="t s1_4">impotent patients, if not all post-RP patients, at</div>
<div id="t1u_4" class="t s1_4">approximately 6 months.</div>
<div id="t1v_4" class="t v1_4 s3_4">25,26</div>
<div id="t1w_4" class="t s1_4">Furthermore, a study</div>
<div id="t1x_4" class="t s1_4">by Mulhall</div>
<div id="t1y_4" class="t s2_4">et al.</div>
<div id="t1z_4" class="t v1_4 s3_4">27</div>
<div id="t20_4" class="t s1_4">suggested that rates of veno-</div>
<div id="t21_4" class="t s1_4">occlusive disease increased through 18 months</div>
<div id="t22_4" class="t s1_4">from 14 to 50% post-RP. Vascular status was also</div>
<div id="t23_4" class="t s1_4">predictive of the likelihood the patient had recov-</div>
<div id="t24_4" class="t s1_4">ered erectile function sufficient for sexual activity;</div>
<div id="t25_4" class="t s1_4">47% of men with normal penile vascular status had</div>
<div id="t26_4" class="t s1_4">recovered erections, while only 8% of patients with</div>
<div id="t27_4" class="t s1_4">venous leak reported sufficient erectile function</div>
<div id="t28_4" class="t s1_4">after 1 year post-RP. These two studies offer insight</div>
<div id="t29_4" class="t s1_4">into the pathophysiology of post-RP ED and suggest</div>
<div id="t2a_4" class="t s1_4">that EP may offset some of the detrimental effects of</div>
<div id="t2b_4" class="t s1_4">the procedure.</div>
<div id="t2c_4" class="t s1_4">For this reason, PDE-5 inhibitor therapy is the</div>
<div id="t2d_4" class="t s1_4">backbone of our institution’s EP program. Pharma-</div>
<div id="t2e_4" class="t s1_4">cotherapy with PDE-5 inhibitors is initiated prior to</div>
<div id="t2f_4" class="t s1_4">surgery given the aforementioned anecdotal reports</div>
<div id="t2g_4" class="t s1_4">and, consistent with many of the case series and</div>
<div id="t2h_4" class="t s1_4">trials reported herein, is continued throughout the</div>
<div id="t2i_4" class="t s1_4">duration of recovery. Low-dose PDE-5 inhibitor</div>
<div id="t2j_4" class="t s1_4">therapy (25 mg) is utilized given the multiple</div>
<div id="t2k_4" class="t s1_4">modality approach that is described below.</div>
<div id="t2l_4" class="t s2_4">Intrauretheral alprostadil suppositories</div>
<div id="t2m_4" class="t s1_4">Alprostadil, a PGE1 analog, is administered to</div>
<div id="t2n_4" class="t s1_4">patients to increase corporal oxygenation by pro-</div>
<div id="t2o_4" class="t s1_4">moting blood flow. This drug is not only most</div>
<div id="t2p_4" class="t s1_4">commonly administered through intracavernosal</div>
<div id="t2q_4" class="t s1_4">injection (ICI), but is also available in the form of</div>
<div id="t2r_4" class="t s1_4">an intrauretheral suppository (MUSE</div>
<div id="t2s_4" class="t v1_4 s6_4">s</div>
<div id="t2t_4" class="t s1_4">, Vivus Inc.,</div>
<div id="t2u_4" class="t s1_4">Mountain View, CA, USA). Montorsi</div>
<div id="t2v_4" class="t s2_4">et al.</div>
<div id="t2w_4" class="t v1_4 s3_4">26</div>
<div id="t2x_4" class="t s1_4">re-</div>
<div id="t2y_4" class="t s1_4">ported that recovery of spontaneous erections was</div>
<div id="t2z_4" class="t s1_4">250% more likely for a patient receiving alprostadil</div>
<div id="t30_4" class="t s1_4">ICI compared with an untreated control. Thus, the</div>
<div id="t31_4" class="t s1_4">concept of localized (for example non-systemic)</div>
<div id="t32_4" class="t s1_4">penile therapy demonstrated dramatic efficacy with-</div>
<div id="t33_4" class="t s1_4">out concern for the systemic consequences of oral</div>
<div id="t34_4" class="t s1_4">pharmaceuticals.</div>
<div id="t35_4" class="t s1_4">The use of intrauretheral alprostadil suppository</div>
<div id="t36_4" class="t s1_4">therapy was documented in 1997, although early</div>
<div id="t37_4" class="t s1_4">results were inconsistent and not reproducible.</div>
<div id="t38_4" class="t v1_4 s3_4">28,29</div>
<div id="t39_4" class="t s1_4">Raina</div>
<div id="t3a_4" class="t s2_4">et al.</div>
<div id="t3b_4" class="t v1_4 s3_4">30</div>
<div id="t3c_4" class="t s1_4">were the first to demonstrate the long-</div>
<div id="t3d_4" class="t s1_4">term effectiveness of this type of therapy in post-RP</div>
<div id="t3e_4" class="t s1_4">patients. Their analysis consisted of a retrospective</div>
<div id="t3f_4" class="t s1_4">review of post-RP patients 6 months after surgery</div>
<div id="t3g_4" class="t s1_4">who subjectively reported ED (defined as the</div>
<div id="t3h_4" class="t s1_4">inability to achieve vaginal penetration). Patients</div>
<div id="t3i_4" class="t s1_4">were told to use MUSE (titrated up to 1000</div>
<div id="t3j_4" class="t s7_4">m</div>
<div id="t3k_4" class="t s1_4">g based</div>
<div id="t3l_4" class="t s1_4">on efficacy) on demand. Overall, 55% were able to</div>
<div id="t3m_4" class="t s1_4">achieve erections sufficient for penetration with</div>
<div id="t3n_4" class="t s1_4">61% of partners reporting satisfaction with this</div>
<div id="t3o_4" class="t s1_4">modality of therapy. Sexual health inventory in men</div>
<div id="t3p_4" class="t s1_4">(SHIM) scores after MUSE use were comparable</div>
<div id="t3q_4" class="t s1_4">with pre-RP scores in these patients.</div>
<div id="t3r_4" class="t s1_4">McCullough</div>
<div id="t3s_4" class="t s2_4">et al.</div>
<div id="t3t_4" class="t v1_4 s3_4">31</div>
<div id="t3u_4" class="t s1_4">adapted the concept of</div>
<div id="t3v_4" class="t s1_4">nightly low-dose PDE-5 inhibitor therapy to com-</div>
<div id="t3w_4" class="t s1_4">pare the effectiveness of this commonly used</div>
<div id="t3x_4" class="t s1_4">approach with nightly MUSE. Patients were rando-</div>
<div id="t3y_4" class="t s1_4">mized into groups using nightly sildenafil or MUSE</div>
<div id="t3z_4" class="t s1_4">(125</div>
<div id="t40_4" class="t s7_4">m</div>
<div id="t41_4" class="t s1_4">g titrated to 250</div>
<div id="t42_4" class="t s7_4">m</div>
<div id="t43_4" class="t s1_4">g within 1 month if toler-</div>
<div id="t44_4" class="t s1_4">able). The study included only men with IIEF scores</div>
<div id="t45_4" class="t s1_4">of at least 26. Treatment was initiated upon catheter</div>
<div id="t46_4" class="t s1_4">removal and was continued for 9 months. After a</div>
<div id="t47_4" class="t s1_4">1-month washout</div>
<div id="t48_4" class="t s1_4">period where</div>
<div id="t49_4" class="t s1_4">patients were</div>
<div id="t4a_4" class="t s1_4">instructed to attempt sexual intercourse without</div>
<div id="t4b_4" class="t s1_4">medication to assist with erections, demand-dose</div>
<div id="t4c_4" class="t s1_4">erectogenic</div>
<div id="t4d_4" class="t s1_4">aids</div>
<div id="t4e_4" class="t s1_4">(sildenafil)</div>
<div id="t4f_4" class="t s1_4">were</div>
<div id="t4g_4" class="t s1_4">provided</div>
<div id="t4h_4" class="t s1_4">to</div>
<div id="t4i_4" class="t s1_4">patients. The final assessment was conducted</div>
<div id="t4j_4" class="t s1_4">11 months after initiating the protocol. IIEF score</div>
<div id="t4k_4" class="t s1_4">rose sequentially and were approximately 50–75%</div>
<div id="t4l_4" class="t s1_4">higher after treatment than at baseline. Intercourse</div>
<div id="t4m_4" class="t s1_4">success rates nearly doubled from the 3 months visit</div>
<div id="t4n_4" class="t v2_4 s8_4">Review and treatment protocol: erectile preservation for RP patients</div>
<div id="t4o_4" class="t v2_4 s9_4">DJ Moskovic</div>
<div id="t4p_4" class="t v2_4 s10_4">et al</div>
<div id="t4q_4" class="t s9_4">184</div>
<div id="t4r_4" class="t v3_4 s11_4">International Journal of Impotence Research</div>

<form>
<input type="button"  tabindex="1"  id="form4_1" name="29 0 R"  pdfFieldName="29 0 R" onclick="window.location.href='11.html';" style="cursor:pointer;"  title="Page 11" />
<input type="button"  tabindex="9"  id="form4_2" name="37 0 R"  pdfFieldName="37 0 R" onclick="window.location.href='11.html';" style="cursor:pointer;"  title="Page 11" />
<input type="button"  tabindex="2"  id="form4_3" name="30 0 R"  pdfFieldName="30 0 R" onclick="window.location.href='11.html';" style="cursor:pointer;"  title="Page 11" />
<input type="button"  tabindex="5"  id="form4_4" name="33 0 R"  pdfFieldName="33 0 R" onclick="window.location.href='11.html';" style="cursor:pointer;"  title="Page 11" />
<input type="button"  tabindex="6"  id="form4_5" name="34 0 R"  pdfFieldName="34 0 R" onclick="window.location.href='11.html';" style="cursor:pointer;"  title="Page 11" />
<input type="button"  tabindex="3"  id="form4_6" name="31 0 R"  pdfFieldName="31 0 R" onclick="window.location.href='11.html';" style="cursor:pointer;"  title="Page 11" />
<input type="button"  tabindex="8"  id="form4_7" name="36 0 R"  pdfFieldName="36 0 R" onclick="window.location.href='11.html';" style="cursor:pointer;"  title="Page 11" />
<input type="button"  tabindex="7"  id="form4_8" name="35 0 R"  pdfFieldName="35 0 R" onclick="window.location.href='11.html';" style="cursor:pointer;"  title="Page 11" />
<input type="button"  tabindex="4"  id="form4_9" name="32 0 R"  pdfFieldName="32 0 R" onclick="window.location.href='11.html';" style="cursor:pointer;"  title="Page 11" />

</form>
<div id="pg4Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg4"><object width="909" height="1212" data="4/4.svg" type="image/svg+xml" id="pdf4" style="width:909px; height:1212px; background-color:white; -moz-transform:scale(1); z-index: 0;"></object></div>
<!--[if lt IE 9]><script type="text/javascript">
var divCount = 172;
for (var i = 1; i < divCount; i++) {
    var div = document.getElementById("t" + i.toString(36) + "_4");
    if (div !== null) {
        div.style.top = (div.offsetTop * 4) + "px";
        div.style.left = (div.offsetLeft * 4) + "px";
        div.style.zoom = "25%";
    }
}
</script><![endif]-->

</div>
